Optimum Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation and Undergoing Percutaneous Coronary Intervention

被引：2
|
作者：
Agarwal, Nayan [1 ]
Mahtta, Dhruv [1 ]
Rambarat, Cecil A. [1 ]
Elgendy, Islam [1 ]
Mahmoud, Ahmed N. [1 ]
机构：
[1] Univ Florida, Dept Med, Gainesville, FL 32611 USA
来源：
BIOMED RESEARCH INTERNATIONAL | 2018年 / 2018卷
关键词：
ATRIAL-FIBRILLATION PATIENTS; DUAL ANTIPLATELET THERAPY; ELEVATION MYOCARDIAL-INFARCTION; ELUTING STENT IMPLANTATION; CARDIOLOGY WORKING GROUP; RHYTHM ASSOCIATION EHRA; ORAL ANTICOAGULATION; TRIPLE THERAPY; AMERICAN-COLLEGE; ARTERY-DISEASE;
D O I：
10.1155/2018/5690640
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Management of patients on long-termanticoagulation requiring percutaneous coronary intervention is challenging. Triple therapy with oral anticoagulant and dual antiplatelet therapy is the standard of care. However, there is no strong evidence to support this strategy. There is emerging data regarding the safety and efficacy of dual therapy with oral anticoagulant and single antiplatelet therapy in these patients. In this comprehensive review we highlight available evidence regarding various antithrombotic regimens' efficacy and safety in patient with coronary artery disease undergoing percutaneous coronary intervention with long-term anticoagulation therapy requirements.
引用
收藏
页数：10
相关论文
共 50 条
  • [1] Optimal Antithrombotic Therapy in Patients Receiving Long-term Oral Anticoagulation Requiring Percutaneous Coronary Intervention "Triple Therapy" or "Triple Threat"
    Tapp, Luke D.
    Lip, Gregory Y. H.
    Lane, Deirdre A.
    CHEST, 2011, 139 (02) : 240 - 243
  • [2] Safety And Efficacy Of Triple Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients Requiring Long-Term Anticoagulation: A Meta-Analysis
    Singh, Param Puneet
    Bedi, Updesh Singh
    Singh, Sarabjeet
    Bhuriya, Rohit
    Bahekar, Amol
    Molnar, Janos
    Arora, Rohit
    Khosla, Sandeep
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A382 - A382
  • [3] Antithrombotic and Antiplatelet Therapy in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention
    Ayoub, Karam
    Marji, Meera
    Nairooz, Ramez
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (05): : 828 - 829
  • [4] Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulation
    Zalewski, Jarostaw
    Undas, Anetta
    Postepy w Kardiologii Interwencyjnej, 2016, 12 (04): : 290 - 302
  • [5] Antithrombotic therapy in patients undergoing percutaneous coronary intervention
    Popma, JJ
    Ohman, EM
    Weitz, J
    Lincoff, M
    Harrington, RA
    Berger, P
    CHEST, 2001, 119 (01) : 321S - 336S
  • [6] Post-PCI Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation
    Madhavan, Mahesh V.
    Kirtane, Ajay J.
    CURRENT CARDIOLOGY REPORTS, 2015, 17 (06)
  • [7] Post-PCI Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation
    Mahesh V. Madhavan
    Ajay J. Kirtane
    Current Cardiology Reports, 2015, 17
  • [8] Periprocedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and intervention
    Rubboli, Andrea
    Colletta, Mauro
    Herzfeld, Jessica
    Sangiorgio, Pietro
    Di Pasquale, Giuseppe
    CORONARY ARTERY DISEASE, 2007, 18 (03) : 193 - 199
  • [9] Evolving Field of Long-term Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation
    Kiviniemi, Tuomas O.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2019, 358 (02): : 91 - 92
  • [10] Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Camaj, Anton
    Miller, Michael S.
    Halperin, Jonathan L.
    Giustino, Gennaro
    CARDIOLOGY CLINICS, 2020, 38 (04) : 551 - 561
12345